nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.429	0.5	CpDpCtD
Trihexyphenidyl—Parkinson's disease—Memantine—Alzheimer's disease	0.429	0.5	CpDpCtD
Trihexyphenidyl—Cognitive impairment—Galantamine—Alzheimer's disease	0.00843	0.0849	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Galantamine—Alzheimer's disease	0.00509	0.0512	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Galantamine—Alzheimer's disease	0.00448	0.0452	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Memantine—Alzheimer's disease	0.00358	0.036	CcSEcCtD
Trihexyphenidyl—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00333	0.0335	CcSEcCtD
Trihexyphenidyl—Paranoia—Galantamine—Alzheimer's disease	0.00323	0.0325	CcSEcCtD
Trihexyphenidyl—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00302	0.0305	CcSEcCtD
Trihexyphenidyl—Paranoia—Donepezil—Alzheimer's disease	0.0025	0.0252	CcSEcCtD
Trihexyphenidyl—Delusion—Donepezil—Alzheimer's disease	0.00241	0.0243	CcSEcCtD
Trihexyphenidyl—Paranoia—Memantine—Alzheimer's disease	0.00227	0.0229	CcSEcCtD
Trihexyphenidyl—Paranoia—Rivastigmine—Alzheimer's disease	0.00222	0.0224	CcSEcCtD
Trihexyphenidyl—Delusion—Memantine—Alzheimer's disease	0.00219	0.022	CcSEcCtD
Trihexyphenidyl—Delusion—Rivastigmine—Alzheimer's disease	0.00214	0.0215	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Galantamine—Alzheimer's disease	0.00192	0.0193	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Donepezil—Alzheimer's disease	0.00146	0.0147	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Memantine—Alzheimer's disease	0.00135	0.0136	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.00132	0.0133	CcSEcCtD
Trihexyphenidyl—Weight decreased—Galantamine—Alzheimer's disease	0.00125	0.0126	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Donepezil—Alzheimer's disease	0.00121	0.0122	CcSEcCtD
Trihexyphenidyl—Dry skin—Donepezil—Alzheimer's disease	0.00113	0.0114	CcSEcCtD
Trihexyphenidyl—Hallucination—Galantamine—Alzheimer's disease	0.0011	0.0111	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Memantine—Alzheimer's disease	0.0011	0.011	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00107	0.0108	CcSEcCtD
Trihexyphenidyl—Dry skin—Memantine—Alzheimer's disease	0.00103	0.0104	CcSEcCtD
Trihexyphenidyl—Dry skin—Rivastigmine—Alzheimer's disease	0.00101	0.0101	CcSEcCtD
Trihexyphenidyl—Weight decreased—Donepezil—Alzheimer's disease	0.000968	0.00974	CcSEcCtD
Trihexyphenidyl—Tension—Galantamine—Alzheimer's disease	0.000944	0.0095	CcSEcCtD
Trihexyphenidyl—Nervousness—Galantamine—Alzheimer's disease	0.000934	0.0094	CcSEcCtD
Trihexyphenidyl—Vision blurred—Galantamine—Alzheimer's disease	0.000906	0.00913	CcSEcCtD
Trihexyphenidyl—Agitation—Galantamine—Alzheimer's disease	0.000884	0.0089	CcSEcCtD
Trihexyphenidyl—Weight decreased—Memantine—Alzheimer's disease	0.000878	0.00885	CcSEcCtD
Trihexyphenidyl—Weight decreased—Rivastigmine—Alzheimer's disease	0.000859	0.00865	CcSEcCtD
Trihexyphenidyl—Hallucination—Donepezil—Alzheimer's disease	0.000852	0.00858	CcSEcCtD
Trihexyphenidyl—Drowsiness—Rivastigmine—Alzheimer's disease	0.000847	0.00853	CcSEcCtD
Trihexyphenidyl—CHRM4—nervous system—Alzheimer's disease	0.000809	0.0713	CbGeAlD
Trihexyphenidyl—CHRM2—forebrain—Alzheimer's disease	0.0008	0.0705	CbGeAlD
Trihexyphenidyl—Confusional state—Galantamine—Alzheimer's disease	0.000791	0.00797	CcSEcCtD
Trihexyphenidyl—CHRM4—central nervous system—Alzheimer's disease	0.000779	0.0687	CbGeAlD
Trihexyphenidyl—Hallucination—Memantine—Alzheimer's disease	0.000773	0.00779	CcSEcCtD
Trihexyphenidyl—Tachycardia—Galantamine—Alzheimer's disease	0.000766	0.00771	CcSEcCtD
Trihexyphenidyl—Hallucination—Rivastigmine—Alzheimer's disease	0.000757	0.00762	CcSEcCtD
Trihexyphenidyl—CHRM2—telencephalon—Alzheimer's disease	0.000735	0.0648	CbGeAlD
Trihexyphenidyl—Tension—Donepezil—Alzheimer's disease	0.000731	0.00736	CcSEcCtD
Trihexyphenidyl—CHRM1—forebrain—Alzheimer's disease	0.000728	0.0642	CbGeAlD
Trihexyphenidyl—Nervousness—Donepezil—Alzheimer's disease	0.000724	0.00729	CcSEcCtD
Trihexyphenidyl—Vision blurred—Donepezil—Alzheimer's disease	0.000702	0.00707	CcSEcCtD
Trihexyphenidyl—Somnolence—Galantamine—Alzheimer's disease	0.000698	0.00703	CcSEcCtD
Trihexyphenidyl—Agitation—Donepezil—Alzheimer's disease	0.000685	0.0069	CcSEcCtD
Trihexyphenidyl—Constipation—Galantamine—Alzheimer's disease	0.000671	0.00676	CcSEcCtD
Trihexyphenidyl—CHRM1—telencephalon—Alzheimer's disease	0.000669	0.059	CbGeAlD
Trihexyphenidyl—Tension—Memantine—Alzheimer's disease	0.000664	0.00669	CcSEcCtD
Trihexyphenidyl—Nervousness—Memantine—Alzheimer's disease	0.000657	0.00662	CcSEcCtD
Trihexyphenidyl—CHRM3—forebrain—Alzheimer's disease	0.000651	0.0574	CbGeAlD
Trihexyphenidyl—Tension—Rivastigmine—Alzheimer's disease	0.00065	0.00654	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Galantamine—Alzheimer's disease	0.000647	0.00651	CcSEcCtD
Trihexyphenidyl—Nervousness—Rivastigmine—Alzheimer's disease	0.000643	0.00647	CcSEcCtD
Trihexyphenidyl—Vision blurred—Memantine—Alzheimer's disease	0.000638	0.00642	CcSEcCtD
Trihexyphenidyl—CHRM5—nervous system—Alzheimer's disease	0.000632	0.0558	CbGeAlD
Trihexyphenidyl—Vision blurred—Rivastigmine—Alzheimer's disease	0.000624	0.00628	CcSEcCtD
Trihexyphenidyl—Agitation—Memantine—Alzheimer's disease	0.000622	0.00626	CcSEcCtD
Trihexyphenidyl—CHRM4—brain—Alzheimer's disease	0.000618	0.0545	CbGeAlD
Trihexyphenidyl—Confusional state—Donepezil—Alzheimer's disease	0.000613	0.00618	CcSEcCtD
Trihexyphenidyl—CHRM5—central nervous system—Alzheimer's disease	0.000609	0.0537	CbGeAlD
Trihexyphenidyl—Agitation—Rivastigmine—Alzheimer's disease	0.000608	0.00613	CcSEcCtD
Trihexyphenidyl—CHRM3—telencephalon—Alzheimer's disease	0.000599	0.0528	CbGeAlD
Trihexyphenidyl—Asthenia—Galantamine—Alzheimer's disease	0.000563	0.00567	CcSEcCtD
Trihexyphenidyl—Confusional state—Memantine—Alzheimer's disease	0.000557	0.00561	CcSEcCtD
Trihexyphenidyl—Confusional state—Rivastigmine—Alzheimer's disease	0.000545	0.00549	CcSEcCtD
Trihexyphenidyl—Somnolence—Donepezil—Alzheimer's disease	0.000541	0.00544	CcSEcCtD
Trihexyphenidyl—Tachycardia—Memantine—Alzheimer's disease	0.000539	0.00543	CcSEcCtD
Trihexyphenidyl—Tachycardia—Rivastigmine—Alzheimer's disease	0.000527	0.00531	CcSEcCtD
Trihexyphenidyl—Constipation—Donepezil—Alzheimer's disease	0.00052	0.00524	CcSEcCtD
Trihexyphenidyl—Dizziness—Galantamine—Alzheimer's disease	0.000519	0.00523	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Donepezil—Alzheimer's disease	0.000501	0.00505	CcSEcCtD
Trihexyphenidyl—Vomiting—Galantamine—Alzheimer's disease	0.000499	0.00502	CcSEcCtD
Trihexyphenidyl—Rash—Galantamine—Alzheimer's disease	0.000495	0.00498	CcSEcCtD
Trihexyphenidyl—Dermatitis—Galantamine—Alzheimer's disease	0.000494	0.00498	CcSEcCtD
Trihexyphenidyl—Headache—Galantamine—Alzheimer's disease	0.000492	0.00495	CcSEcCtD
Trihexyphenidyl—Somnolence—Memantine—Alzheimer's disease	0.000491	0.00494	CcSEcCtD
Trihexyphenidyl—CHRM5—brain—Alzheimer's disease	0.000483	0.0426	CbGeAlD
Trihexyphenidyl—Somnolence—Rivastigmine—Alzheimer's disease	0.00048	0.00484	CcSEcCtD
Trihexyphenidyl—Constipation—Memantine—Alzheimer's disease	0.000472	0.00476	CcSEcCtD
Trihexyphenidyl—Nausea—Galantamine—Alzheimer's disease	0.000466	0.00469	CcSEcCtD
Trihexyphenidyl—Constipation—Rivastigmine—Alzheimer's disease	0.000462	0.00465	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Memantine—Alzheimer's disease	0.000455	0.00458	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000445	0.00448	CcSEcCtD
Trihexyphenidyl—Asthenia—Donepezil—Alzheimer's disease	0.000436	0.00439	CcSEcCtD
Trihexyphenidyl—CHRM2—nervous system—Alzheimer's disease	0.000434	0.0383	CbGeAlD
Trihexyphenidyl—CHRM2—central nervous system—Alzheimer's disease	0.000418	0.0368	CbGeAlD
Trihexyphenidyl—Dizziness—Donepezil—Alzheimer's disease	0.000402	0.00405	CcSEcCtD
Trihexyphenidyl—Asthenia—Memantine—Alzheimer's disease	0.000396	0.00399	CcSEcCtD
Trihexyphenidyl—CHRM1—nervous system—Alzheimer's disease	0.000395	0.0348	CbGeAlD
Trihexyphenidyl—Asthenia—Rivastigmine—Alzheimer's disease	0.000388	0.0039	CcSEcCtD
Trihexyphenidyl—Vomiting—Donepezil—Alzheimer's disease	0.000387	0.00389	CcSEcCtD
Trihexyphenidyl—Rash—Donepezil—Alzheimer's disease	0.000383	0.00386	CcSEcCtD
Trihexyphenidyl—Dermatitis—Donepezil—Alzheimer's disease	0.000383	0.00386	CcSEcCtD
Trihexyphenidyl—Headache—Donepezil—Alzheimer's disease	0.000381	0.00384	CcSEcCtD
Trihexyphenidyl—CHRM1—central nervous system—Alzheimer's disease	0.00038	0.0335	CbGeAlD
Trihexyphenidyl—Dizziness—Memantine—Alzheimer's disease	0.000365	0.00368	CcSEcCtD
Trihexyphenidyl—Nausea—Donepezil—Alzheimer's disease	0.000361	0.00364	CcSEcCtD
Trihexyphenidyl—Dizziness—Rivastigmine—Alzheimer's disease	0.000357	0.0036	CcSEcCtD
Trihexyphenidyl—CHRM3—nervous system—Alzheimer's disease	0.000354	0.0312	CbGeAlD
Trihexyphenidyl—Vomiting—Memantine—Alzheimer's disease	0.000351	0.00354	CcSEcCtD
Trihexyphenidyl—Rash—Memantine—Alzheimer's disease	0.000348	0.00351	CcSEcCtD
Trihexyphenidyl—Dermatitis—Memantine—Alzheimer's disease	0.000348	0.0035	CcSEcCtD
Trihexyphenidyl—Headache—Memantine—Alzheimer's disease	0.000346	0.00348	CcSEcCtD
Trihexyphenidyl—Vomiting—Rivastigmine—Alzheimer's disease	0.000343	0.00346	CcSEcCtD
Trihexyphenidyl—Rash—Rivastigmine—Alzheimer's disease	0.000341	0.00343	CcSEcCtD
Trihexyphenidyl—CHRM3—central nervous system—Alzheimer's disease	0.00034	0.03	CbGeAlD
Trihexyphenidyl—Dermatitis—Rivastigmine—Alzheimer's disease	0.00034	0.00343	CcSEcCtD
Trihexyphenidyl—Headache—Rivastigmine—Alzheimer's disease	0.000338	0.00341	CcSEcCtD
Trihexyphenidyl—CHRM2—brain—Alzheimer's disease	0.000332	0.0293	CbGeAlD
Trihexyphenidyl—Nausea—Memantine—Alzheimer's disease	0.000328	0.0033	CcSEcCtD
Trihexyphenidyl—Nausea—Rivastigmine—Alzheimer's disease	0.000321	0.00323	CcSEcCtD
Trihexyphenidyl—CHRM1—brain—Alzheimer's disease	0.000302	0.0266	CbGeAlD
Trihexyphenidyl—CHRM3—brain—Alzheimer's disease	0.00027	0.0238	CbGeAlD
Trihexyphenidyl—Biperiden—CYP2D6—Alzheimer's disease	0.000242	0.562	CrCbGaD
Trihexyphenidyl—Oxybutynin—CYP2D6—Alzheimer's disease	0.000189	0.438	CrCbGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CREB1—Alzheimer's disease	1.25e-05	0.000419	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.24e-05	0.000415	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	1.24e-05	0.000414	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADAM10—Alzheimer's disease	1.23e-05	0.000411	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.23e-05	0.00041	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCL2—Alzheimer's disease	1.23e-05	0.00041	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.22e-05	0.000406	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—S100B—Alzheimer's disease	1.22e-05	0.000406	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.21e-05	0.000405	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—BCHE—Alzheimer's disease	1.2e-05	0.000402	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.2e-05	0.000401	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.19e-05	0.000398	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	1.19e-05	0.000397	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	1.19e-05	0.000396	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	1.18e-05	0.000395	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	1.18e-05	0.000394	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.18e-05	0.000393	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	1.17e-05	0.000392	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	1.17e-05	0.000391	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—S100B—Alzheimer's disease	1.16e-05	0.000389	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	1.16e-05	0.000389	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF2—Alzheimer's disease	1.16e-05	0.000387	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	1.14e-05	0.000382	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	1.14e-05	0.000381	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PLCB1—Alzheimer's disease	1.13e-05	0.000379	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.13e-05	0.000377	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.13e-05	0.000377	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	1.13e-05	0.000376	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF1R—Alzheimer's disease	1.12e-05	0.000374	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.11e-05	0.000372	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF2—Alzheimer's disease	1.11e-05	0.00037	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.1e-05	0.000369	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	1.1e-05	0.000368	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ABCA1—Alzheimer's disease	1.1e-05	0.000367	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.09e-05	0.000364	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	1.08e-05	0.000362	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	1.08e-05	0.000361	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.08e-05	0.000361	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.08e-05	0.000359	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—LPL—Alzheimer's disease	1.07e-05	0.000359	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF1R—Alzheimer's disease	1.07e-05	0.000358	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.07e-05	0.000358	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.07e-05	0.000356	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.07e-05	0.000356	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MEF2C—Alzheimer's disease	1.06e-05	0.000355	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.06e-05	0.000355	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	1.06e-05	0.000355	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	1.06e-05	0.000354	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.05e-05	0.000352	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.05e-05	0.000351	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PRKCG—Alzheimer's disease	1.04e-05	0.000349	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.03e-05	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SST—Alzheimer's disease	1.03e-05	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.03e-05	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	1.03e-05	0.000345	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	1.03e-05	0.000345	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SST—Alzheimer's disease	1.03e-05	0.000345	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.03e-05	0.000344	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—LPL—Alzheimer's disease	1.03e-05	0.000343	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	1.03e-05	0.000343	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.03e-05	0.000343	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	1.02e-05	0.000342	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.02e-05	0.000341	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.02e-05	0.000341	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.02e-05	0.000341	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MEF2C—Alzheimer's disease	1.02e-05	0.00034	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.02e-05	0.00034	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NGF—Alzheimer's disease	1.02e-05	0.00034	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.01e-05	0.000338	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APP—Alzheimer's disease	1.01e-05	0.000337	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APP—Alzheimer's disease	1.01e-05	0.000336	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	9.99e-06	0.000334	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APP—Alzheimer's disease	9.96e-06	0.000333	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCR5—Alzheimer's disease	9.89e-06	0.00033	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	9.74e-06	0.000325	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	9.69e-06	0.000323	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—Alzheimer's disease	9.68e-06	0.000323	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	9.65e-06	0.000322	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	9.56e-06	0.000319	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	9.52e-06	0.000318	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	9.49e-06	0.000317	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	9.48e-06	0.000317	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	9.47e-06	0.000316	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—HMOX1—Alzheimer's disease	9.43e-06	0.000315	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	9.39e-06	0.000314	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	9.27e-06	0.00031	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CALM1—Alzheimer's disease	9.03e-06	0.000302	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	9e-06	0.000301	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	9e-06	0.000301	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	8.91e-06	0.000298	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	8.88e-06	0.000297	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	8.85e-06	0.000296	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	8.82e-06	0.000295	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	8.79e-06	0.000294	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	8.76e-06	0.000293	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	8.71e-06	0.000291	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	8.67e-06	0.00029	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	8.65e-06	0.000289	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	8.64e-06	0.000289	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	8.63e-06	0.000288	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—LPL—Alzheimer's disease	8.63e-06	0.000288	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	8.62e-06	0.000288	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	8.62e-06	0.000288	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	8.6e-06	0.000287	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	8.59e-06	0.000287	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	8.56e-06	0.000286	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	8.54e-06	0.000285	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	8.52e-06	0.000285	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—F2—Alzheimer's disease	8.49e-06	0.000283	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	8.3e-06	0.000277	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	8.23e-06	0.000275	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	8.2e-06	0.000274	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	8.17e-06	0.000273	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—F2—Alzheimer's disease	8.13e-06	0.000271	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	8.1e-06	0.00027	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	7.95e-06	0.000266	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	7.81e-06	0.000261	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	7.79e-06	0.00026	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	7.78e-06	0.00026	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MTHFR—Alzheimer's disease	7.77e-06	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	7.73e-06	0.000258	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	7.71e-06	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—INS—Alzheimer's disease	7.69e-06	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	7.56e-06	0.000253	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	7.55e-06	0.000252	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	7.53e-06	0.000251	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	7.46e-06	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	7.45e-06	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	7.43e-06	0.000248	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	7.4e-06	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—INS—Alzheimer's disease	7.36e-06	0.000246	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CALM1—Alzheimer's disease	7.26e-06	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	7.24e-06	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	7.24e-06	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—Alzheimer's disease	7.23e-06	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	7.21e-06	0.000241	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	7.17e-06	0.00024	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CAV1—Alzheimer's disease	7.17e-06	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	7.15e-06	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	7.14e-06	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	7.12e-06	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	7.08e-06	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	7.04e-06	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	7.01e-06	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	6.95e-06	0.000232	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	6.86e-06	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	6.83e-06	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	6.77e-06	0.000226	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	6.74e-06	0.000225	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	6.67e-06	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	6.65e-06	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	6.58e-06	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	6.53e-06	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	6.51e-06	0.000217	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	6.46e-06	0.000216	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	6.44e-06	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARG—Alzheimer's disease	6.3e-06	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—INS—Alzheimer's disease	6.18e-06	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	6.09e-06	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	6.07e-06	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	6.07e-06	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	6.07e-06	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	6.05e-06	0.000202	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	6.05e-06	0.000202	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	6.01e-06	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	6.01e-06	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	5.99e-06	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	5.99e-06	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	5.99e-06	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	5.93e-06	0.000198	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	5.79e-06	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	5.78e-06	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	5.77e-06	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	5.72e-06	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—F2—Alzheimer's disease	5.72e-06	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	5.72e-06	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—F2—Alzheimer's disease	5.7e-06	0.00019	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	5.69e-06	0.00019	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—F2—Alzheimer's disease	5.65e-06	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.6e-06	0.000187	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	5.58e-06	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	5.53e-06	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.53e-06	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	5.48e-06	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	5.44e-06	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NOS3—Alzheimer's disease	5.42e-06	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	5.26e-06	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	5.25e-06	0.000175	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	5.25e-06	0.000175	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	5.24e-06	0.000175	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	5.21e-06	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	5.2e-06	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	5.19e-06	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—INS—Alzheimer's disease	5.18e-06	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—INS—Alzheimer's disease	5.17e-06	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	5.14e-06	0.000172	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—INS—Alzheimer's disease	5.12e-06	0.000171	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	5.1e-06	0.00017	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	5.08e-06	0.00017	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	5.04e-06	0.000168	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	5.03e-06	0.000168	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	5.02e-06	0.000168	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	5.01e-06	0.000167	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	5e-06	0.000167	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—Alzheimer's disease	4.96e-06	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	4.95e-06	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	4.86e-06	0.000162	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	4.65e-06	0.000155	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	4.55e-06	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	4.53e-06	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	4.49e-06	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	4.46e-06	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	4.27e-06	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.89e-06	0.00013	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	3.88e-06	0.00013	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	3.86e-06	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	3.85e-06	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.84e-06	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	3.83e-06	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	3.82e-06	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	3.81e-06	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	3.78e-06	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	3.67e-06	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	3.55e-06	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	3.54e-06	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	3.54e-06	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	3.53e-06	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	3.51e-06	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	3.5e-06	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	3.49e-06	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	3.36e-06	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.27e-06	0.000109	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	3.26e-06	0.000109	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	3.23e-06	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	3.22e-06	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	3.1e-06	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.01e-06	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	3e-06	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	2.97e-06	9.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.97e-06	9.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AKT1—Alzheimer's disease	2.49e-06	8.32e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.47e-06	8.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	2.47e-06	8.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	2.44e-06	8.16e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.26e-06	7.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.26e-06	7.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.24e-06	7.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.09e-06	6.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.08e-06	6.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.06e-06	6.89e-05	CbGpPWpGaD
